LMBRD1

Across TCGA pan-cancer cohorts, LMBRD1 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LMBRD1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LMBRD1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types LMBRD1 is over-expressed in tumor, although a few such as HNSC and CCRCC show the opposite, repressed pattern.

HNSC, CCRCC, and LSCC are the cancer types where LMBRD1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LMBRD1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	−0.349	<.001	11	view →
CCRCC	All	III,IV	−0.321	<.001	11	view →
LSCC	Male	II,III,IV	−0.597	<.001	9	view →
PDAC	Female	All	−0.579	.024	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

LMBRD1–HNSC

Open the HNSC breakdown →